Executive Director Oncology R&D, Early Development in Basking Ridge, NJ at DSI

Date Posted: 9/11/2020

Job Snapshot

Job Description

Join a Legacy of Innovation 110 Years and Counting!

With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.

Job Summary:

Oversees multiple programs, alliances, mega trials, such as global clinical development program for multiple product candidates with one or more indications or a single large program with multiple Ph II/III studies; Reviews regulatory documents from cross functional, holistic perspective. Provides senior level clinical representation at meetings with health authorities; Leads the creation of developmental and regulatory strategy; Accountable for performance of CROs; Routine interactions with senior management of CRO/ARO, as needed; Accountable for clinical development plans, protocol profiles and sections of key submission documents; Represents Clinical Development as team leader or as supervisor of team leaders; Accountable for Clinical Development input into commercial strategy including biomarker strategy; Thought partner in driving Business Development decisions in collaboration with External Scientific Affairs dept.

  • Study strategy: Interacts with leaders of each function to develop study strategy; Approves project or TA-level biomarker strategy in collaboration with Translational Medicine and Clinical Pharmacology; Attends regulatory agency meetings and leads clinical strategy discussions
  • Study planning and execution: Develops prospective contingency plans for management of key risks across a large project or a portfolio of projects or across the Therapeutic Area; Clearly defines priorities and high level execution plans across projects within and outside of Daiichi Sankyo; Supports effective communication and decision-making process cross-functionally and cross-regionally at department level
  • Study Outputs: For mega-studies/programs, consults on responses to IRBs and HA; Has strong understanding of statistics and study design principles applicable to primary efficacy endpoints in registrational trials to critically assess study conclusions
  • Medical Monitoring Planning (MD only): Oversees and coordinates Sponsor oversight of CRO Medical Monitoring activities, including plan for internal communication and issue escalation with Clinical Study Lead (CSL)
  • Medical Surveillance (MD Only): Documents ongoing Medical Monitoring review of data for safety (with Clinical Safety Pharmacovigiliance) and quality at project level; Ensures global consistency of Medical Monitoring activities; Defines or contributes to department level surveillance activities across projects
  • External collaboration: Ensure continuous, effective alignment within / between CRO and vendors; For large, multiple indication project in late development, develops and leads Ad-Board with top tier KOLs for project level strategic advice; Develops and leads steering committee for Phase 3 registrational study; Consults with KOLS for advice on complex development or safety issues; Maintains and leads external collaborations and advisory panels at department level
  • People Management: Assign staff with appropriate training and experience or arrange requisite support to lead large study teams, coordinate complex studies, lead projects, and/or ensure proper medical oversight; Monitor and manage direct report’s performance in such roles, ensuring that there is proper understanding of task complexity and management of key risks; Participate in department’s planning for staff and cross-functional staffing plans for the Therapeutic Area.
  • Additional Non-Study related activities: Routine senior management interactions; Influential relationship with top KOLs; Thought partner with Ext Scientific Affairs on Business Development activities for late stage compounds; Committee member, in-licensing and acquisitions
Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

  • PharmD, PhD, MD, or equivalent; Postgraduate training in TA or related specialty, or past successes
  • 8 years (3 years managing Clinical Development group)
  • Strategic Thinking, Clinical Trials Knowledge, Influencing Skills, Scientific Knowledge, Therapeutic Expertise, Drug Development, Critical Thinking, Team Leadership
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.